data_1dtv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dtv _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.786 0 N-CA-C 119.396 2.518 . . . . 0.0 119.396 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -112.05 -160.47 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.147 . . . . 0.0 109.614 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -70.84 122.02 19.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.0 109.689 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG21 ' A' ' 4' ' ' THR . 0.4 OUTLIER -74.92 133.08 76.3 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.097 -1.002 . . . . 0.0 108.732 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.91 153.54 37.65 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.086 1.857 . . . . 0.0 110.082 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -107.8 153.05 23.55 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -118.17 -169.67 1.74 Allowed 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 90.5 p -150.79 135.34 17.18 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' ASN . 13.8 m-85 -122.65 127.9 49.94 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.654 ' CD2' ' CE1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -95.31 120.59 35.81 Favored 'General case' 0 C--N 1.258 -3.405 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 33.3 m -89.14 122.8 32.79 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 103.351 -2.833 . . . . 0.0 103.351 178.859 -78.347 -58.238 96.719 105.87 2.019 103.187 -121.343 -34.895 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.654 ' CE1' ' CD2' ' A' ' 10' ' ' LEU . 3.7 m-85 -109.15 144.37 37.31 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-O 122.882 1.325 . . . . 0.0 111.804 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.605 ' O ' ' OH ' ' A' ' 65' ' ' TYR . 46.5 tt0 -136.62 144.86 48.88 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 13' ' ' GLN . 19.4 Cg_endo -57.26 -9.05 4.2 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 120.616 0.877 . . . . 0.0 111.693 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -143.94 15.63 1.74 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.945 -1.097 . . . . 0.0 110.274 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 1.2 mt-30 -161.66 140.9 9.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.586 -1.322 . . . . 0.0 109.502 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.606 ' CG2' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -138.65 121.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.152 -0.967 . . . . 0.0 109.082 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.548 ' O ' ' CE1' ' A' ' 20' ' ' PHE . 5.5 m -112.67 124.57 52.86 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 119.179 -1.009 . . . . 0.0 109.12 179.982 -42.34 -33.992 -75.037 107.032 2.028 105.096 109.631 -142.36 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.64 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 0.5 OUTLIER -100.39 138.14 37.86 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.393 -1.323 . . . . 0.0 108.666 -179.764 93.007 149.023 89.695 103.592 2.01 103.312 42.651 -179.569 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CE1' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -130.15 140.85 50.73 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.821 -0.751 . . . . 0.0 110.245 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -109.24 123.74 65.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 175.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 71.2 m -113.56 145.01 41.91 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.083 -176.941 -62.617 -91.176 120.823 103.218 2.014 103.139 -94.814 -65.975 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.556 ' NE ' ' HB3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -113.64 30.04 7.54 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.669 -1.212 . . . . 0.0 109.425 177.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.59 -32.03 0.04 OUTLIER Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.088 -1.008 . . . . 0.0 110.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.564 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -145.7 -148.87 0.26 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.034 -1.274 . . . . 0.0 111.232 -177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.665 ' O ' ' CZ ' ' A' ' 53' ' ' TYR . . . -135.11 -176.12 0.55 Allowed Pre-proline 0 N--CA 1.504 2.241 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.608 ' HB3' ' CD2' ' A' ' 20' ' ' PHE . 37.4 Cg_endo -83.15 164.39 15.12 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.615 1.544 . . . . 0.0 109.393 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.704 ' CD1' ' CE2' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -94.66 111.55 54.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -73.23 103.22 1.57 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.488 2.126 . . . . 0.0 111.952 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.05 1.6 4.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.508 -0.745 . . . . 0.0 110.164 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -132.07 11.7 4.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.986 -1.071 . . . . 0.0 109.346 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.16 -120.28 0.91 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 4.7 pt-20 -147.94 170.92 16.64 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.281 -1.129 . . . . 0.0 109.327 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 2.7 m -150.49 147.04 27.02 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 122.398 1.094 . . . . 0.0 109.888 179.367 -34.895 -121.343 96.719 103.187 2.019 105.87 -58.238 -78.347 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 4.1 m-20 -154.17 167.94 12.8 Favored Pre-proline 0 N--CA 1.503 2.213 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.379 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 23.8 Cg_endo -62.12 128.64 24.6 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.845 1.697 . . . . 0.0 111.441 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.745 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 1.2 t60 -134.69 153.14 78.73 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.16 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.745 ' HD2' ' CD2' ' A' ' 37' ' ' HIS . 31.8 Cg_endo -69.12 -129.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.299 -2.048 0 N-CA-C 104.095 -3.079 . . . . 0.0 104.095 173.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.498 ' CG2' ' SG ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -162.35 107.44 1.2 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 119.746 -1.847 . . . . 0.0 110.057 177.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.58 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . . . -67.82 -172.27 0.13 Allowed Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 40' ' ' ALA . 34.4 Cg_endo -78.33 -26.61 6.02 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 120.855 1.037 . . . . 0.0 109.42 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.64 ' CE3' ' CG2' ' A' ' 63' ' ' ILE . 24.6 p-90 -75.32 -30.11 60.22 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.572 -0.705 . . . . 0.0 110.36 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 53.9 t -64.29 -57.2 10.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.291 1.043 . . . . 0.0 109.56 179.683 -179.569 42.651 89.695 103.312 2.01 103.592 149.023 93.007 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 ttm105 -69.72 -34.63 74.14 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.136 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 2.1 tp10 -73.03 -27.76 61.95 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.51 -0.744 . . . . 0.0 112.967 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.531 ' HA3' ' OG1' ' A' ' 61' ' ' THR . . . -106.72 -13.18 22.76 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.863 -1.636 . . . . 0.0 111.296 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.545 ' CA ' ' HB ' ' A' ' 61' ' ' THR . . . -98.02 90.41 4.89 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.856 -1.379 . . . . 0.0 108.691 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.515 ' O ' ' CG1' ' A' ' 48' ' ' VAL . 8.4 p -132.07 51.23 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.688 -0.632 . . . . 0.0 110.518 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.701 ' O ' ' CD1' ' A' ' 50' ' ' TRP . 22.1 pt-20 -152.08 -163.84 1.83 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.701 ' CD1' ' O ' ' A' ' 49' ' ' GLU . 41.6 m95 -161.94 149.8 14.68 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.575 ' CG2' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -153.76 149.48 21.11 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.199 -0.938 . . . . 0.0 108.833 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 51' ' ' VAL . 31.6 Cg_endo -72.97 113.65 3.83 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.98 1.787 . . . . 0.0 111.08 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.704 ' CE2' ' CD1' ' A' ' 28' ' ' LEU . 4.1 t80 -111.41 158.46 19.07 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.157 0.979 . . . . 0.0 110.251 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.688 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -20.81 -90.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.53 ' OG1' ' CB ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -84.67 7.97 18.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.563 -1.335 . . . . 0.0 111.236 -176.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 53' ' ' TYR . . . -175.35 -150.83 8.15 Favored Glycine 0 N--CA 1.501 3.003 0 C-N-CA 117.346 -2.359 . . . . 0.0 111.779 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.556 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 3.1 tp60 -122.44 128.74 51.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 96.2 m -133.49 142.33 48.2 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.293 0.568 . . . . 0.0 110.979 -178.936 -65.975 -94.814 120.823 103.139 2.014 103.218 -91.176 -62.617 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.69 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -113.67 164.13 14.09 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.62 ' HB ' ' CD2' ' A' ' 20' ' ' PHE . 1.8 t -160.09 162.22 34.02 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.201 -1.8 . . . . 0.0 112.76 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.545 ' HB ' ' CA ' ' A' ' 47' ' ' ALA . 11.6 t -142.75 152.29 42.15 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -128.93 150.88 50.19 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 117.074 -1.85 . . . . 0.0 109.947 178.043 -142.36 109.631 -75.037 105.096 2.028 107.032 -33.992 -42.34 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.64 ' CG2' ' CE3' ' A' ' 42' ' ' TRP . 1.8 pt -137.87 159.25 69.4 Favored Pre-proline 0 C--N 1.29 -2.021 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.369 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 50.6 Cg_endo -87.35 105.94 0.62 Allowed 'Trans proline' 0 C--N 1.299 -2.051 0 C-N-CA 123.286 2.657 . . . . 0.0 108.659 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.606 ' CD1' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -109.95 -110.36 0.33 Allowed 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 117.505 -1.678 . . . . 0.0 111.258 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.414 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 1.5 m -76.24 26.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.272 -2.781 0 O-C-N 120.75 -1.219 . . . . 0.0 110.515 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.512 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.786 0 N-CA-C 119.396 2.518 . . . . 0.0 119.396 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -112.05 -160.47 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.147 . . . . 0.0 109.614 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -70.84 122.02 19.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.0 109.689 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.92 133.08 76.3 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.097 -1.002 . . . . 0.0 108.732 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.91 153.54 37.65 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.086 1.857 . . . . 0.0 110.082 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -107.8 153.05 23.55 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -118.17 -169.67 1.74 Allowed 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 90.5 p -150.79 135.34 17.18 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' ASN . 13.8 m-85 -122.65 127.9 49.94 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.088 HD22 ' CE1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -95.31 120.59 35.81 Favored 'General case' 0 C--N 1.258 -3.405 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 33.3 m -89.14 122.8 32.79 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 103.351 -2.833 . . . . 0.0 103.351 178.859 -78.347 -58.238 96.719 105.87 2.019 103.187 -121.343 -34.895 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 1.088 ' CE1' HD22 ' A' ' 10' ' ' LEU . 3.7 m-85 -109.15 144.37 37.31 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-O 122.882 1.325 . . . . 0.0 111.804 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.605 ' O ' ' OH ' ' A' ' 65' ' ' TYR . 46.5 tt0 -136.62 144.86 48.88 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 13' ' ' GLN . 19.4 Cg_endo -57.26 -9.05 4.2 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 120.616 0.877 . . . . 0.0 111.693 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -143.94 15.63 1.74 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.945 -1.097 . . . . 0.0 110.274 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 1.2 mt-30 -161.66 140.9 9.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.586 -1.322 . . . . 0.0 109.502 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.041 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -138.65 121.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.152 -0.967 . . . . 0.0 109.082 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 5.5 m -112.67 124.57 52.86 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 119.179 -1.009 . . . . 0.0 109.12 179.982 -42.34 -33.992 -75.037 107.032 2.028 105.096 109.631 -142.36 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.654 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 0.5 OUTLIER -100.39 138.14 37.86 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.393 -1.323 . . . . 0.0 108.666 -179.764 93.007 149.023 89.695 103.592 2.01 103.312 42.651 -179.569 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CE1' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -130.15 140.85 50.73 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.821 -0.751 . . . . 0.0 110.245 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -109.24 123.74 65.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 175.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 71.2 m -113.56 145.01 41.91 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.083 -176.941 -62.617 -91.176 120.823 103.218 2.014 103.139 -94.814 -65.975 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' NE ' ' HB3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -113.64 30.04 7.54 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.669 -1.212 . . . . 0.0 109.425 177.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.59 -32.03 0.04 OUTLIER Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.088 -1.008 . . . . 0.0 110.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.883 ' HB2' ' OG1' ' A' ' 55' ' ' THR . . . -145.7 -148.87 0.26 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.034 -1.274 . . . . 0.0 111.232 -177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -135.11 -176.12 0.55 Allowed Pre-proline 0 N--CA 1.504 2.241 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 37.4 Cg_endo -83.15 164.39 15.12 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.615 1.544 . . . . 0.0 109.393 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.817 HD12 ' CD2' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -94.66 111.55 54.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' PRO . 33.7 Cg_endo -73.23 103.22 1.57 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.488 2.126 . . . . 0.0 111.952 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.05 1.6 4.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.508 -0.745 . . . . 0.0 110.164 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -132.07 11.7 4.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.986 -1.071 . . . . 0.0 109.346 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.16 -120.28 0.91 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 4.7 pt-20 -147.94 170.92 16.64 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.281 -1.129 . . . . 0.0 109.327 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 2.7 m -150.49 147.04 27.02 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 122.398 1.094 . . . . 0.0 109.888 179.367 -34.895 -121.343 96.719 103.187 2.019 105.87 -58.238 -78.347 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 4.1 m-20 -154.17 167.94 12.8 Favored Pre-proline 0 N--CA 1.503 2.213 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.379 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 23.8 Cg_endo -62.12 128.64 24.6 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.845 1.697 . . . . 0.0 111.441 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.63 ' CG ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -134.69 153.14 78.73 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.16 -178.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.63 ' HD2' ' CG ' ' A' ' 37' ' ' HIS . 31.8 Cg_endo -69.12 -129.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.299 -2.048 0 N-CA-C 104.095 -3.079 . . . . 0.0 104.095 173.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.98 HG22 ' SG ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -162.35 107.44 1.2 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 119.746 -1.847 . . . . 0.0 110.057 177.095 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -67.82 -172.27 0.13 Allowed Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 34.4 Cg_endo -78.33 -26.61 6.02 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 120.855 1.037 . . . . 0.0 109.42 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.654 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 24.6 p-90 -75.32 -30.11 60.22 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.572 -0.705 . . . . 0.0 110.36 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.98 ' SG ' HG22 ' A' ' 39' ' ' THR . 53.9 t -64.29 -57.2 10.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.291 1.043 . . . . 0.0 109.56 179.683 -179.569 42.651 89.695 103.312 2.01 103.592 149.023 93.007 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 ttm105 -69.72 -34.63 74.14 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.136 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 2.1 tp10 -73.03 -27.76 61.95 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.51 -0.744 . . . . 0.0 112.967 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' OG1' ' A' ' 61' ' ' THR . . . -106.72 -13.18 22.76 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.863 -1.636 . . . . 0.0 111.296 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' CA ' ' HB ' ' A' ' 61' ' ' THR . . . -98.02 90.41 4.89 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.856 -1.379 . . . . 0.0 108.691 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -132.07 51.23 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.688 -0.632 . . . . 0.0 110.518 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.725 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 22.1 pt-20 -152.08 -163.84 1.83 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.701 ' CD1' ' O ' ' A' ' 49' ' ' GLU . 41.6 m95 -161.94 149.8 14.68 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.981 HG22 ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -153.76 149.48 21.11 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.199 -0.938 . . . . 0.0 108.833 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.981 ' HD2' HG22 ' A' ' 51' ' ' VAL . 31.6 Cg_endo -72.97 113.65 3.83 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.98 1.787 . . . . 0.0 111.08 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.817 ' CD2' HD12 ' A' ' 28' ' ' LEU . 4.1 t80 -111.41 158.46 19.07 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.157 0.979 . . . . 0.0 110.251 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.727 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -20.81 -90.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.883 ' OG1' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -84.67 7.97 18.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.563 -1.335 . . . . 0.0 111.236 -176.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 53' ' ' TYR . . . -175.35 -150.83 8.15 Favored Glycine 0 N--CA 1.501 3.003 0 C-N-CA 117.346 -2.359 . . . . 0.0 111.779 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.596 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 3.1 tp60 -122.44 128.74 51.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 96.2 m -133.49 142.33 48.2 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.293 0.568 . . . . 0.0 110.979 -178.936 -65.975 -94.814 120.823 103.139 2.014 103.218 -91.176 -62.617 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.725 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -113.67 164.13 14.09 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.628 ' HB ' ' CD2' ' A' ' 20' ' ' PHE . 1.8 t -160.09 162.22 34.02 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.201 -1.8 . . . . 0.0 112.76 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.558 ' HB ' ' CA ' ' A' ' 47' ' ' ALA . 11.6 t -142.75 152.29 42.15 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -128.93 150.88 50.19 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 117.074 -1.85 . . . . 0.0 109.947 178.043 -142.36 109.631 -75.037 105.096 2.028 107.032 -33.992 -42.34 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.893 HG13 HG23 ' A' ' 17' ' ' VAL . 1.8 pt -137.87 159.25 69.4 Favored Pre-proline 0 C--N 1.29 -2.021 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.369 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 50.6 Cg_endo -87.35 105.94 0.62 Allowed 'Trans proline' 0 C--N 1.299 -2.051 0 C-N-CA 123.286 2.657 . . . . 0.0 108.659 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 1.041 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -109.95 -110.36 0.33 Allowed 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 117.505 -1.678 . . . . 0.0 111.258 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.59 HG13 ' CD2' ' A' ' 65' ' ' TYR . 1.5 m -76.24 26.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.272 -2.781 0 O-C-N 120.75 -1.219 . . . . 0.0 110.515 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.512 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.786 0 N-CA-C 119.396 2.518 . . . . 0.0 119.396 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -112.05 -160.47 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.147 . . . . 0.0 109.614 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -70.84 122.02 19.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.0 109.689 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.92 133.08 76.3 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.097 -1.002 . . . . 0.0 108.732 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.91 153.54 37.65 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.086 1.857 . . . . 0.0 110.082 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -107.8 153.05 23.55 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -118.17 -169.67 1.74 Allowed 'General case' 0 C--N 1.269 -2.895 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 90.5 p -150.79 135.34 17.18 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' ASN . 13.8 m-85 -122.65 127.9 49.94 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.088 HD22 ' CE1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -95.31 120.59 35.81 Favored 'General case' 0 C--N 1.258 -3.405 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 33.3 m -89.14 122.8 32.79 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 103.351 -2.833 . . . . 0.0 103.351 178.859 -78.347 -58.238 96.719 105.87 2.019 103.187 -121.343 -34.895 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 1.088 ' CE1' HD22 ' A' ' 10' ' ' LEU . 3.7 m-85 -109.15 144.37 37.31 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-O 122.882 1.325 . . . . 0.0 111.804 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.605 ' O ' ' OH ' ' A' ' 65' ' ' TYR . 46.5 tt0 -136.62 144.86 48.88 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 13' ' ' GLN . 19.4 Cg_endo -57.26 -9.05 4.2 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 120.616 0.877 . . . . 0.0 111.693 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -143.94 15.63 1.74 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.945 -1.097 . . . . 0.0 110.274 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 1.2 mt-30 -161.66 140.9 9.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.586 -1.322 . . . . 0.0 109.502 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.041 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -138.65 121.39 18.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.152 -0.967 . . . . 0.0 109.082 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 5.5 m -112.67 124.57 52.86 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 119.179 -1.009 . . . . 0.0 109.12 179.982 -42.34 -33.992 -75.037 107.032 2.028 105.096 109.631 -142.36 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.654 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 0.5 OUTLIER -100.39 138.14 37.86 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.393 -1.323 . . . . 0.0 108.666 -179.764 93.007 149.023 89.695 103.592 2.01 103.312 42.651 -179.569 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CE1' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -130.15 140.85 50.73 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.821 -0.751 . . . . 0.0 110.245 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -109.24 123.74 65.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 175.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 71.2 m -113.56 145.01 41.91 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.083 -176.941 -62.617 -91.176 120.823 103.218 2.014 103.139 -94.814 -65.975 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' NE ' ' HB3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -113.64 30.04 7.54 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.669 -1.212 . . . . 0.0 109.425 177.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.59 -32.03 0.04 OUTLIER Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.088 -1.008 . . . . 0.0 110.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.883 ' HB2' ' OG1' ' A' ' 55' ' ' THR . . . -145.7 -148.87 0.26 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.034 -1.274 . . . . 0.0 111.232 -177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -135.11 -176.12 0.55 Allowed Pre-proline 0 N--CA 1.504 2.241 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 37.4 Cg_endo -83.15 164.39 15.12 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.615 1.544 . . . . 0.0 109.393 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.817 HD12 ' CD2' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -94.66 111.55 54.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' PRO . 33.7 Cg_endo -73.23 103.22 1.57 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.488 2.126 . . . . 0.0 111.952 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.05 1.6 4.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.508 -0.745 . . . . 0.0 110.164 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -132.07 11.7 4.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.986 -1.071 . . . . 0.0 109.346 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.16 -120.28 0.91 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 4.7 pt-20 -147.94 170.92 16.64 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.281 -1.129 . . . . 0.0 109.327 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 2.7 m -150.49 147.04 27.02 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 122.398 1.094 . . . . 0.0 109.888 179.367 -34.895 -121.343 96.719 103.187 2.019 105.87 -58.238 -78.347 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 4.1 m-20 -154.17 167.94 12.8 Favored Pre-proline 0 N--CA 1.503 2.213 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.379 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 23.8 Cg_endo -62.12 128.64 24.6 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.845 1.697 . . . . 0.0 111.441 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.759 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 1.2 t60 -134.69 153.14 78.73 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.16 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.759 ' HD2' ' CD2' ' A' ' 37' ' ' HIS . 31.8 Cg_endo -69.12 -129.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.299 -2.048 0 N-CA-C 104.095 -3.079 . . . . 0.0 104.095 173.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.98 HG22 ' SG ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -162.35 107.44 1.2 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 119.746 -1.847 . . . . 0.0 110.057 177.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -67.82 -172.27 0.13 Allowed Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 34.4 Cg_endo -78.33 -26.61 6.02 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 120.855 1.037 . . . . 0.0 109.42 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.654 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 24.6 p-90 -75.32 -30.11 60.22 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.572 -0.705 . . . . 0.0 110.36 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.98 ' SG ' HG22 ' A' ' 39' ' ' THR . 53.9 t -64.29 -57.2 10.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.291 1.043 . . . . 0.0 109.56 179.683 -179.569 42.651 89.695 103.312 2.01 103.592 149.023 93.007 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 ttm105 -69.72 -34.63 74.14 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.136 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 2.1 tp10 -73.03 -27.76 61.95 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.51 -0.744 . . . . 0.0 112.967 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' OG1' ' A' ' 61' ' ' THR . . . -106.72 -13.18 22.76 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.863 -1.636 . . . . 0.0 111.296 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' CA ' ' HB ' ' A' ' 61' ' ' THR . . . -98.02 90.41 4.89 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.856 -1.379 . . . . 0.0 108.691 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 48' ' ' VAL . 8.4 p -132.07 51.23 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.688 -0.632 . . . . 0.0 110.518 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.725 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 22.1 pt-20 -152.08 -163.84 1.83 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.701 ' CD1' ' O ' ' A' ' 49' ' ' GLU . 41.6 m95 -161.94 149.8 14.68 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.981 HG22 ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -153.76 149.48 21.11 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.199 -0.938 . . . . 0.0 108.833 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.981 ' HD2' HG22 ' A' ' 51' ' ' VAL . 31.6 Cg_endo -72.97 113.65 3.83 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.98 1.787 . . . . 0.0 111.08 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.817 ' CD2' HD12 ' A' ' 28' ' ' LEU . 4.1 t80 -111.41 158.46 19.07 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.157 0.979 . . . . 0.0 110.251 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.727 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -20.81 -90.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.883 ' OG1' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -84.67 7.97 18.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.563 -1.335 . . . . 0.0 111.236 -176.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 53' ' ' TYR . . . -175.35 -150.83 8.15 Favored Glycine 0 N--CA 1.501 3.003 0 C-N-CA 117.346 -2.359 . . . . 0.0 111.779 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.596 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 3.1 tp60 -122.44 128.74 51.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 96.2 m -133.49 142.33 48.2 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.293 0.568 . . . . 0.0 110.979 -178.936 -65.975 -94.814 120.823 103.139 2.014 103.218 -91.176 -62.617 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.725 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -113.67 164.13 14.09 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.628 ' HB ' ' CD2' ' A' ' 20' ' ' PHE . 1.8 t -160.09 162.22 34.02 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.201 -1.8 . . . . 0.0 112.76 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.558 ' HB ' ' CA ' ' A' ' 47' ' ' ALA . 11.6 t -142.75 152.29 42.15 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -128.93 150.88 50.19 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 117.074 -1.85 . . . . 0.0 109.947 178.043 -142.36 109.631 -75.037 105.096 2.028 107.032 -33.992 -42.34 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.893 HG13 HG23 ' A' ' 17' ' ' VAL . 1.8 pt -137.87 159.25 69.4 Favored Pre-proline 0 C--N 1.29 -2.021 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.369 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 50.6 Cg_endo -87.35 105.94 0.62 Allowed 'Trans proline' 0 C--N 1.299 -2.051 0 C-N-CA 123.286 2.657 . . . . 0.0 108.659 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 1.041 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -109.95 -110.36 0.33 Allowed 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 117.505 -1.678 . . . . 0.0 111.258 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.59 HG13 ' CD2' ' A' ' 65' ' ' TYR . 1.5 m -76.24 26.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.272 -2.781 0 O-C-N 120.75 -1.219 . . . . 0.0 110.515 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.512 178.953 . . . . . . . . 2 2 . 1 stop_ save_